Cognitive disorders among people living with HIV

HIV has become a chronic disease. It is of paramount importance to explore all comorbidities in our aging population. The Swiss HIV Cohort embarked in this journey in 2013 by creating the Metabolic and Aging (sub)-Cohort. In Lausanne we are leading the Neuro-HIV studies. The NAMACO (Neurocognitive Assessment in the Meatabolic and Aging Cohort) study is one of the largest neuro-hiv cohort. 

Selected publications


  • Dr PD Katie Darling MD PhD
  • Prof Renaud Du Pasquier MD
  • Prof Arseny Sokolov MD
  • Dr José Damas MD
  • Dr Paraskevas Filippidis MD and the NAMACO study group

Open positions

  • No current position available
 Last updated on 07/05/2024 at 15:34